IQVIA Holdings Inc. (IQV) Operating Margin: 13.86%
Is IQVIA Holdings Inc.’s operating margin high or low?
IQVIA Holdings Inc.'s operating margin of 13.86% is 18% above its 5-year average of 11.74%, near the high end of its 5-year range (6.44%–14.29%).
The operating margin for IQVIA Holdings Inc. (IQV) is 13.86% as of Wednesday, June 10, 2026. It is below its 12-month average by 2.08% (14.15%).
IQV Operating Margin Chart
IQV Average Operating Margin Chart
IQV Current vs Average Operating Margin Chart
IQV Operating Margin Metrics
OPERATING MARGIN
13.86%
OPERATING MARGIN AVG TTM
14.15%
OPERATING MARGIN AVG 3Y
13.50%
OPERATING MARGIN AVG 5Y
11.74%
OPERATING MARGIN AVG 10Y
10.24%
OPERATING MARGIN AVG 15Y
9.92%
OPERATING MARGIN AVG 20Y
9.92%
CURRENT VS TTM AVG
-2.08%
CURRENT VS 3Y AVG
+2.70%
CURRENT VS 5Y AVG
+18.02%
CURRENT VS 10Y AVG
+35.29%
CURRENT VS 15Y AVG
+39.67%
CURRENT VS 20Y AVG
+39.67%
IQV Competitors' Operating Margin
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IQVIA Holdings Inc. (IQV) | $30.60B | 13.86% | 14.15% | 13.50% | 11.74% |
| Medline Inc. (MDLN) | $30.90B | 7.04% | 8.25% | 6.70% | 6.70% |
| Centene Corporation (CNC) | $31.94B | -3.68% | -0.98% | 0.21% | 0.84% |
| DexCom, Inc. (DXCM) | $29.24B | 21.45% | 17.22% | 16.09% | 15.13% |
| Biogen Inc. (BIIB) | $29.00B | 15.65% | 22.44% | 23.65% | 25.70% |
| Zoetis Inc. (ZTS) | $34.20B | 37.57% | 37.33% | 36.70% | 36.14% |
| Veeva Systems Inc. (VEEV) | $26.73B | 28.79% | 26.93% | 23.33% | 24.40% |
| Agilent Technologies, Inc. (A) | $37.17B | 21.50% | 22.07% | 21.88% | 20.79% |
| Waters Corporation (WAT) | $23.83B | 17.08% | 28.07% | 28.30% | 28.33% |
| Mettler-Toledo International Inc. (MTD) | $22.85B | 28.00% | 28.45% | 28.53% | 27.71% |
Operating Efficiency
Gross Margin
26.1%
Operating Margin
13.9%
IQVIA Holdings Inc. Operating Margin Formula & Definition
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
IQVIA Holdings Inc. Operating Margin FAQ
- What is the operating margin for IQVIA Holdings Inc. (IQV)?
- The operating margin for IQV stock is 13.86%.
- Is IQVIA Holdings Inc.'s operating margin high or low?
- IQVIA Holdings Inc.'s operating margin of 13.86% is 18% above its 5-year average of 11.74%, near the high end of its 5-year range (6.44%–14.29%).
- What is the TTM average operating margin for IQVIA Holdings Inc. (IQV)?
- The TTM average operating margin for IQV stock is 14.15%.
- What is the 3Y average operating margin for IQVIA Holdings Inc. (IQV)?
- The 3Y average operating margin for IQV stock is 13.50%.
- What is the 5Y average operating margin for IQVIA Holdings Inc. (IQV)?
- The 5Y average operating margin for IQV stock is 11.74%.
- What is the 10Y average operating margin for IQVIA Holdings Inc. (IQV)?
- The 10Y average operating margin for IQV stock is 10.24%.
- What is the 15Y average operating margin for IQVIA Holdings Inc. (IQV)?
- The 15Y average operating margin for IQV stock is 9.92%.
- What is the 20Y average operating margin for IQVIA Holdings Inc. (IQV)?
- The 20Y average operating margin for IQV stock is 9.92%.
IQVIA Holdings Inc. Operating Margin History
| DATE | OPERATING MARGIN |
|---|---|
| 2025-12-31 | 14.02% |
| 2024-12-31 | 14.29% |
| 2023-12-31 | 13.19% |
| 2022-12-31 | 12.48% |
| 2021-12-31 | 10.04% |
| 2020-12-31 | 6.44% |
| 2019-12-31 | 7.01% |
| 2018-12-31 | 7.12% |
| 2017-12-31 | 7.41% |
| 2016-12-31 | 9.42% |
| 2015-12-31 | 11.27% |
| 2014-12-31 | 10.81% |
| 2013-12-31 | 9.07% |
| 2012-12-31 | 8.15% |
| 2011-12-31 | 7.98% |
| 2010-12-31 | 10.07% |
Related Metrics
About IQVIA Holdings Inc.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ari Bousbib